<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Parry, Nicola</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Kim, Yangha</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Thermogenesis-Based Obesity Interventions</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">13-13</style></pages><abstract><style  face="normal" font="default" size="100%">This article reviews the role of thermogenic agents in the management of cardiometabolic risk. The global obesity pandemic represents a major public health problem, in particular since overweight and obesity are well-known risk factors that predispose patients to cardiovascular diseasse and type 2 diabetes [Seale P, Lazar MA. Diabetes 2009].</style></abstract><number><style face="normal" font="default" size="100%">16</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>